Our findings highlight the role of mRNA acetylation by NAT10 in maintaining GBM stemness through JARID2 mRNA stabilization and suggest that targeting this mechanism may provide a novel approach for the treatment of GBM. This evidence concerns the gene JARID2 and glioblastoma.